Use of Dengvaxia® in Australian Travellers: a case series

Yan Zhu; Deborah J Mills; Christine Mills; Colleen L Lau; Luis Furuya-Kanamori

doi:10.1093/jtm/taae052

Use of Dengvaxia® in Australian Travellers: a case series

J Travel Med. 2024 Apr 5:taae052. doi: 10.1093/jtm/taae052. Online ahead of print.

Authors

Yan Zhu^{1

2}, Deborah J Mills^{1

3}, Christine Mills³, Colleen L Lau¹, Luis Furuya-Kanamori¹

Affiliations

¹ UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Australia.
² Zhuhai International Travel Healthcare Center of China Customs, Zhuhai, China.
³ Dr Deb The Travel Doctor, Travel Medicine Alliance, Brisbane, Australia.

PMID: 38579018
DOI: 10.1093/jtm/taae052

Abstract

Dengvaxia is the only licensed dengue vaccine in Australia, but rarely used. We report the experience of using Dengvaxia in seven Australian travellers. Main reasons for opting for vaccination were travel to dengue-endemic regions and severe symptoms during the prior dengue infection. The vaccine was well tolerated by all travellers.

Keywords: adverse; dengue; event; reaction; vaccine.